108 related articles for article (PubMed ID: 6335492)
1. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VII. [2-14C]-5-ethyl-1-(2'-deoxy-beta-D-ribofuranosyl)uracil.
Lee YW; Giziewicz JB; Knaus EE; Wiebe LI
Int J Appl Radiat Isot; 1984 Nov; 35(11):1063-6. PubMed ID: 6335492
[TBL] [Abstract][Full Text] [Related]
2. Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracil.
Abrams DN; Lee YW; Mercer JR; Knaus EE; Wiebe LI
Br J Radiol; 1986 Mar; 59(699):263-70. PubMed ID: 2936414
[TBL] [Abstract][Full Text] [Related]
3. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--VIII. Synthesis and tissue distribution of N-[2-(hydroxyethoxy) methyl]-5-[3H]methyluracil.
Lee YW; Iwashina T; Gati WP; Knaus EE; Wiebe LI
Int J Appl Radiat Isot; 1985 May; 36(5):395-8. PubMed ID: 4018900
[TBL] [Abstract][Full Text] [Related]
4. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VI. 1-(3'-[36Cl]-chloro-, 1-(3'-[82Br]-bromo- and 1-(3'-[123I]-Iodo-3'-deoxy-beta-D-arabinofuranosyl)uracil.
Lee YW; Mercer JR; Wiebe LI; Knaus EE
Int J Appl Radiat Isot; 1984 Nov; 35(11):1057-61. PubMed ID: 6526522
[TBL] [Abstract][Full Text] [Related]
5. Tumor uptake studies of D,L-[5-14C]ornithine and D,L-2-difluoromethyl [5-14C]ornithine.
Ishiwata K; Abe Y; Matsuzawa T; Ido T
Int J Rad Appl Instrum B; 1988; 15(2):119-22. PubMed ID: 3130336
[TBL] [Abstract][Full Text] [Related]
6. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--V. 6-[36Cl]chlorouracil, 6-[82Br]bromouracil and 6-[123I]iodouracil.
Lee YW; Abrams DN; Wiebe LI; Knaus EE
Int J Nucl Med Biol; 1984; 11(3-4):262-6. PubMed ID: 6549392
[No Abstract] [Full Text] [Related]
7. 2-14C-1-(2'-deoxy-beta-D-ribofuranosyl)-5-ethyluracil: synthesis and biotransformation in rats.
Kaul R; Kiefer G; Erhardt S; Hempel B
J Pharm Sci; 1980 May; 69(5):531-4. PubMed ID: 7381737
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and tumor uptake of 5-halo-1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)[2-14C]uracils.
Mercer JR; Knaus EE; Wiebe LI
J Med Chem; 1987 Apr; 30(4):670-5. PubMed ID: 2951522
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging.
Toyohara J; Kumata K; Fukushi K; Irie T; Suzuki K
J Nucl Med; 2006 Oct; 47(10):1717-22. PubMed ID: 17015909
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biodistribution of [4-14C]-5-bromo-6-methoxy-5,6-dihydro-prodrug derivatives of 5-ethyl-2'-deoxyuridine.
Cheraghali AM; Morin KW; Kumar R; Knaus EE; Wiebe LI
Drug Des Discov; 1994 Jul; 12(1):53-61. PubMed ID: 7578807
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent.
Tatsuta N; Suzuki N; Mochizuki T; Koya K; Kawakami M; Shishido T; Motoji N; Kuroiwa H; Shigematsu A; Chen LB
Cancer Chemother Pharmacol; 1999; 43(4):295-301. PubMed ID: 10071980
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of 5-ethyl-2'-deoxyuridine and its 5,6-dihydro prodrugs in murine lung and its potential clinical application.
Cheraghali AM; Morin KW; Kumar R; Knaus EE; Wiebe LI
J Pharm Pharmacol; 1995 Jul; 47(7):595-600. PubMed ID: 8568628
[TBL] [Abstract][Full Text] [Related]
13. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--III. 2'-[82Br]-bromo-2'-deoxyuridine.
Lee YW; Knaus EE; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):109-112. PubMed ID: 113355
[No Abstract] [Full Text] [Related]
14. Effect of 5-diazouracil on the catabolism of circulating pyrimidines in rat liver and kidneys.
Holstege A; Pausch J; Gerok W
Cancer Res; 1986 Nov; 46(11):5576-81. PubMed ID: 3756903
[TBL] [Abstract][Full Text] [Related]
15. Development of labeled thymidine analogs for imaging tumor proliferation.
Shields AF; Grierson JR; Kozawa SM; Zheng M
Nucl Med Biol; 1996 Jan; 23(1):17-22. PubMed ID: 9004909
[TBL] [Abstract][Full Text] [Related]
16. Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.
Akel G; Benard P; Canal P; Soula G
Cancer Chemother Pharmacol; 1986; 17(2):121-6. PubMed ID: 3719893
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
Stüben J; Port R; Bertram B; Bollow U; Hull WE; Schaper M; Pohl J; Wiessler M
Cancer Chemother Pharmacol; 1996; 38(4):355-65. PubMed ID: 8674159
[TBL] [Abstract][Full Text] [Related]
18. Tumor uptake study of 18F-labeled N-acetylneuraminic acids.
Ishiwata K; Ido T; Nakajima T; Ohrui H; Kijima-Suda I; Itoh M
Int J Rad Appl Instrum B; 1990; 17(4):363-7. PubMed ID: 2387744
[TBL] [Abstract][Full Text] [Related]
19. Tumor selective enhancement of radioactivity uptake in mice treated with alpha-difluoromethylornithine prior to administration of 14C-putrescine.
Chaney JE; Kobayashi K; Goto R; Digenis GA
Life Sci; 1983 Mar; 32(11):1237-41. PubMed ID: 6403786
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and tumor uptake of 5-82Br- and 5-131I-labeled 5-halo-1-(2-fluoro-2-deoxy-beta-D-ribofuranosyl)uracils.
Mercer JR; Xu LH; Knaus EE; Wiebe LI
J Med Chem; 1989 Jun; 32(6):1289-94. PubMed ID: 2524593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
